Corcept Therapeutics Incorporated · NASDAQ:CORT
Guyer William sold 16,300 Corcept Therapeutics Incorporated shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 12, 2026
On Aug 10, 2026, Guyer William (Chief Development Officer) sold 16,300 Corcept Therapeutics Incorporated shares at an average US$113.43 for US$1.85M under a trading plan, leaving 3,985 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 16,300 shares
- Price
- US$113.43 average (US$113.18 to US$114.04)
- Value
- US$1.85M
- Holding after
- 3,985 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Option exercise | 16,300 | US$21.65 | 20,285 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 11,530 | US$113.18 | 8,755 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 4,770 | US$114.04 | 3,985 | Direct |
Source
Related
- Corcept Therapeutics Incorporated
- Guyer William
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Guyer William · Sep 3, 2026
- Form 4 · Guyer William · Aug 6, 2026
- Form 4 · Guyer William · Jul 8, 2026
- Form 4 · Guyer William · Jun 4, 2026
- Form 4 · Guyer William · Jun 3, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026